Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Peter Bach
Pharma
Biogen’s Aduhelm likely to cost more than $56,000: expert
How much will Aduhelm really cost? An analysis shows that Biogen has underestimated the figure, partly by failing to account for waste.
Kevin Dunleavy
Jul 14, 2021 7:18am
Don't give up yet on biosimilars: Gottlieb
Aug 26, 2019 11:28am
It's time to give up on biosims and regulate prices: experts
Apr 18, 2019 12:33pm
Keytruda flat dose could cost an extra $1B annually
Jul 17, 2017 11:15am
Louisiana wants HHS head Price to sidestep Gilead hep C patents
May 5, 2017 11:59am
U.S. drug premiums cover global R&D bill—and a whole lot more
Mar 10, 2017 9:08am
